• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4670594)   Today's Articles (3697)
For: Ferrández JSR, García AL, Alonso-Vega GG, González AO, García TM. Successful Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment in a HIV Patient With Swallowing Difficulties. Ann Pharmacother 2020;55:556-557. [PMID: 32862660 DOI: 10.1177/1060028020953631] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]  Open
Number Cited by Other Article(s)
1
LoFaso M, Marchionda O, Bass S, Torbic H, Blackewicz C, Pallotta A. Evaluation of Dolutegravir- and Bictegravir-Based Antiretroviral Regimen Utilization in Patients who Cannot Take Medications by Mouth. Open Forum Infect Dis 2023;10:ofad554. [PMID: 38088984 PMCID: PMC10712287 DOI: 10.1093/ofid/ofad554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2023] [Accepted: 11/08/2023] [Indexed: 12/30/2023]  Open
2
Johnson TM, Rivera CG. Crushed vs dissolved bictegravir/emtricitabine/tenofovir alafenamide. Am J Health Syst Pharm 2023;80:180-181. [PMID: 36377971 DOI: 10.1093/ajhp/zxac346] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2022] [Indexed: 11/17/2022]  Open
3
Brizzi M, Pérez SE, Michienzi SM, Badowski ME. Long-acting injectable antiretroviral therapy: will it change the future of HIV treatment? Ther Adv Infect Dis 2023;10:20499361221149773. [PMID: 36741193 PMCID: PMC9893397 DOI: 10.1177/20499361221149773] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2022] [Accepted: 12/12/2022] [Indexed: 02/03/2023]  Open
4
Hocqueloux L, Lefeuvre S, Bois J, Brucato S, Alix A, Valentin C, Peyro-Saint-Paul L, Got L, Fournel F, Dargere S, Prazuck T, Fournier A, Gregoire N, McNicholl I, Parienti JJ. Bioavailability of dissolved and crushed single tablets of bictegravir, emtricitabine, tenofovir alafenamide in healthy adults: the SOLUBIC randomized crossover study. J Antimicrob Chemother 2022;78:161-168. [PMID: 36322475 PMCID: PMC9780524 DOI: 10.1093/jac/dkac369] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2022] [Accepted: 10/10/2022] [Indexed: 11/06/2022]  Open
5
Rowe SM, Clary JC, Drummond M, Derrick C, Sanasi K, Bookstaver PB. Increased viral load in a hospitalized patient on treatment with crushed bictegravir/emtricitabine/tenofovir alafenamide: A case report and review of the literature. Am J Health Syst Pharm 2022;79:1330-1336. [PMID: 35511892 DOI: 10.1093/ajhp/zxac120] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA